Caxton Associates LP Bio Techne Corp Transaction History

Caxton Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $897,541 - $1.09 Million	12,532 New	12,532 $929,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $212,752 - $295,063	753 New	753 $214,000
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $381,450 - $525,837	-1,078 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $491,729 - $566,014	1,078 New	1,078 $558,000
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $398,875 - $470,932	-2,173 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $295,723 - $435,556	2,173 New	2,173 $431,000

598

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.97B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.